Fraschini F, Scaglione F, Coppi G, Piazza G, Marchi E, Montoli C C, Scarpazza G
Int J Clin Pharmacol Res. 1987;7(2):129-33.
Fifteen patients suffering from obstructive chronic bronchopneumonia in a clinical steady-state phase received 0.6 g of tiopronin once a day during 10 days per os. The lymphocyte subsets (OKT3, OKT4 and OKT8) have been identified in peripheral blood and in bronchoalveolar lavage liquid (BAL) before and after treatment and phagocytosis has been evaluated in pulmonary alveolar macrophages (PAM) (phagocytosis index, phagocytosis percentage, superoxide-ion production). A highly significant improvement in the phagocytosis process has been observed in the PAM, as well as an increase in the number of lymphocytes T3 and in the T4/T8 ratio (due to an increase in T4 lymphocytes) in the BAL; while in peripheral blood T3 and T4 lymphocytes and the T4/T8 ratio only showed a nonsignificant increase after treatment. The possible mechanisms on which these variations are based have been investigated.
15例处于临床稳定期的阻塞性慢性支气管肺炎患者口服硫普罗宁,每日0.6g,共10天。治疗前后分别对外周血和支气管肺泡灌洗液(BAL)中的淋巴细胞亚群(OKT3、OKT4和OKT8)进行鉴定,并对肺泡巨噬细胞(PAM)的吞噬作用进行评估(吞噬指数、吞噬百分比、超氧离子产生)。观察到PAM的吞噬过程有高度显著改善,BAL中T3淋巴细胞数量及T4/T8比值增加(由于T4淋巴细胞增加);而外周血中T3和T4淋巴细胞以及T4/T8比值在治疗后仅呈非显著增加。已对这些变化所基于的可能机制进行了研究。